Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Restless legs syndrome (Willis-Ekbom disease)

Neurology · Symptom or situation · updated 2026-10-29

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: 8.5% in France (10.8% of women, 5.8% of men); daily symptoms in 1.9% of the population [1]

Initial tests

Fasting sample.

Fasting laboratory tests, in the morning

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Follow-up of a clinically significant syndrome

Fasting sample.

Regularly, in the morning (no interval set by the guidelines)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Sources (5)
  1. Leclair-Visonneau L, Vecchierini MF, Schröder C, Charley Monaca C. Consensus français sous l'égide de la SFRMS sur le syndrome des jambes sans repos : comment poser le diagnostic ? Médecine du sommeil. 2019;16:97-105 (version française de : French consensus: how to diagnose restless legs syndrome. Rev Neurol (Paris). 2018;174:508-14).
  2. Winkelman JW, Berkowski JA, DelRosso LM, et al. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2025;21(1):137-52 (publié en ligne en septembre 2024).
  3. Allen RP, Picchietti DL, Auerbach M, et al.; International Restless Legs Syndrome Study Group (IRLSSG). Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med. 2018;41:27-44.
  4. Garcia-Borreguero D, Stillman P, Benes H, et al. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurol. 2011;11:28 (groupe de travail de l'European Restless Legs Syndrome Study Group, EURLSSG).
  5. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 1213 (ferritine).